Creative Planning
XENE icon

Creative Planning’s Xenon Pharmaceuticals XENE Stock Holding History

Creative Planning’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73M Buy
29,818
+10,618
+55% +$489K ﹤0.01% 2014
2025
Q4 		$861K Buy
19,200
+5,990
+45% +$252K ﹤0.01% 2400
2025
Q3 		$530K Buy
+13,210
New +$465K ﹤0.01% 2661
2015
Q1 		– Sell
-8,000
Closed -$158K – 4435
2014
Q4 		$158K Buy
+8,000
New +$117K ﹤0.01% 1280

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Creative Planning's XENE Position: Q1 2026 in Review

Creative Planning increased its Xenon Pharmaceuticals (XENE) stake by 55% in Q1 2026, buying an estimated $489K and bringing the position to 29,818 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Creative Planning first reported a position in XENE in Q4 2014 and has held it in 4 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • Creative Planning held 29,818 shares of Xenon Pharmaceuticals worth $1.73M as of Q1 2026.
  • Creative Planning bought 10,618 Xenon Pharmaceuticals shares in Q1 2026, an estimated $489K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2014 holding.
  • Creative Planning first reported a position in Xenon Pharmaceuticals in Q4 2014 and has held it in 4 quarters since.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.